why choose us

300×250 Ad Slot

Research Article: Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients

Date Published: 2024-01-16

Abstract:
Background and aims: Rheumatoid arthritis (RA) patients are currently treated with biological agents mostly aimed at cytokine blockade, such as tumor necrosis factor-alpha (TNF?). Currently, there are no biomarkers to predict therapy response to these agents. Here, we aimed to predict response to adalimumab (ADA) treatment in RA patients using DNA methylation in peripheral blood (PBL).

No summary available.

300×250 Ad Slot